Cargando…
Is there a need to reconsider the use of metformin in COVID-19 patients with type 2 diabetes mellitus?
INTRODUCTION: Diabetes has been linked with poorer outcomes in coronavirus disease (COVID-19) patients. However, the question to whether continue or withdraw metformin therapy in COVID-19 patients with type 2 diabetes mellitus remains contentious. This study aims to investigate the association betwe...
Autores principales: | Lazarus, Gilbert, Suhardi, Indira P., Wiyarta, Elvan, Rasyidah, Rufiah A., Barliana, Julie D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922709/ https://www.ncbi.nlm.nih.gov/pubmed/33679040 http://dx.doi.org/10.1007/s13410-021-00924-w |
Ejemplares similares
-
Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
por: Levy, Juliana, et al.
Publicado: (2010) -
CD44 Variant Exon 6 Isoform Expression as a Potential Predictor of Lymph Node Metastasis in Invasive Breast Carcinoma of No Special Type
por: Rustamadji, Primariadewi, et al.
Publicado: (2021) -
Exploring the Integrated Role of AKT2, CD44v6, And MT1-MMP as Predictors of Axillary Lymph Node Metastasis in Invasive Breast Carcinoma of No Special Type
por: Rustamadji, Primariadewi, et al.
Publicado: (2022) -
Reconsidering the Basal Proportion of Insulin Dose: Glycemic and Microvascular Outcomes in Type 1 Diabetes Mellitus
por: Pozos-Varela, Francisco Javier, et al.
Publicado: (2021) -
A call to reconsider the new diagnostic criteria for gestational diabetes mellitus
por: Bell, Katy J.L., et al.
Publicado: (2023)